{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T10:21:53Z","timestamp":1770286913406,"version":"3.49.0"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T00:00:00Z","timestamp":1709683200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/ http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Introduction:<\/jats:title>\n            <jats:p>Systemic lupus erythematosus (SLE) is a systemic immune disease that classically occurs in young to middle-aged women and may present with cutaneous, renal, haematologic, neurological, and\/or other symptoms at the time of diagnosis. Late-onset SLE or SLE in the elderly is a subtype that differs from classic SLE in terms of age group, clinical symptoms, organ involvement and severity.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Case presentation:<\/jats:title>\n            <jats:p>A 63-year-old female noted to have pancytopenia. The patient was diagnosed with lupus upon obtaining clinical presentations and serological marker, along with high titres of the antinuclear antibody and\/or anti-double-stranded DNA antibody. The patient was managed with glucocorticoids and mycophenolate mofetil therapy, which led to a rapid response.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Discussion:<\/jats:title>\n            <jats:p>Late-onset SLE accounts for 2\u201312% of SLE patients with a minimum age of onset of 50 years and older, leading to significant delays in diagnosis. Late-onset SLE differs from early-onset SLE in terms of sex and ethnicity prevalence, clinical symptoms and signs, development of organ damage, disease activity and severity, and prognosis. Some studies have also shown that late-stage SLE patients have higher rates of RF and anti-Ro\/anti-La antibody positivity, lower complement titre, and higher incidence of elevated creatinine and decreased creatinine clearance. First-line treatment of pancytopenia is glucocorticoid. In refractory cases, rituximab and immunosuppressants can be used.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>It is important to assess any unusual presentation of SLEs when clinical suspicion remains high and conducting further laboratory and imaging investigation.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ms9.0000000000001891","type":"journal-article","created":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T08:00:31Z","timestamp":1709625631000},"page":"3025-3028","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Pancytopenia as a first presentation of late-onset systemic lupus erythematosus: a case report"],"prefix":"10.1097","volume":"86","author":[{"given":"Ghina","family":"Haidar","sequence":"first","affiliation":[{"name":"Rheumatology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naram","family":"Khalayli","sequence":"additional","affiliation":[{"name":"Psychiatry, Faculty of Medicine, Damascus University, Damascus"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tasneem","family":"Drie","sequence":"additional","affiliation":[{"name":"Rheumatology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mhd Homam","family":"Safiah","sequence":"additional","affiliation":[{"name":"Syrian Private University, Daraa, Syria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maysoun","family":"Kudsi","sequence":"additional","affiliation":[{"name":"Rheumatology"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2024,5]]},"reference":[{"key":"R1-20250806","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s42358-023-00297-0","article-title":"Comparison of clinical features, disease activity, treatment and outcomes between late-onset and early-onset patients with systemic lupus erythematosus. A sex- and year at diagnosis-matched controlled study","volume":"63","author":"Mongkolchaiarunya","year":"2023","journal-title":"Adv Rheumatol"},{"key":"R2-20250806","first-page":"003972","article-title":"Genital ulcers associated with systemic lupus erythematosus - what are the possible causes? A case report","volume":"10","author":"Kudsi","year":"2023","journal-title":"Eur J Case Rep Intern Med"},{"key":"R3-20250806","doi-asserted-by":"crossref","first-page":"2054358118793397","DOI":"10.1177\/2054358118793397","article-title":"Late-onset systemic lupus erythematosus with lupus nephritis in a 74-year-old male: a brief case and review","volume":"5","author":"Kutky","year":"2018","journal-title":"Can J Kidney Health Dis"},{"key":"R4-20250806","first-page":"e22938","article-title":"A practical perspective of the hematologic manifestations of systemic lupus erythematosus","volume":"14","author":"Santacruz","year":"2022","journal-title":"Cureus"},{"key":"R5-20250806","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1097\/JS9.0000000000000373","article-title":"The SCARE 2023 guideline: updating consensus Surgical CAse REport (SCARE) guidelines","volume":"109","author":"Sohrabi","year":"2023","journal-title":"Int J Surg Lond Engl"},{"key":"R6-20250806","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/art.40930","article-title":"2019 European League Against Rheumatism\/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus","volume":"71","author":"Aringer","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"R7-20250806","first-page":"e30330","article-title":"An overview of systemic lupus erythematosus (SLE) pathogenesis, classification, and management","volume":"14","author":"Ameer","year":"2022","journal-title":"Cureus"},{"key":"R8-20250806","doi-asserted-by":"crossref","first-page":"1759720X211073001","DOI":"10.1177\/1759720X211073001","article-title":"Hydroxychloroquine in systemic lupus erythematosus: overview of current knowledge","volume":"14","author":"Dima","year":"2022","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"suppl5","key":"R9-20250806","doi-asserted-by":"crossref","first-page":"v69","DOI":"10.1093\/rheumatology\/keaa403","article-title":"Treating systemic lupus erythematosus in the 21st century: new drugs and new perspectives on old drugs","volume":"59","author":"Ruiz-Irastorza","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"R10-20250806","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.rceng.2023.11.001","article-title":"Treatment of systemic lupus erythematosus: new therapeutic options","volume":"223","author":"Gonz\u00e1lez-Garc\u00eda","year":"2023","journal-title":"Revista Cl\u00ednica Espa\u00f1ola (English Edition)"},{"key":"R11-20250806","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1136\/annrheumdis-2019-215089","article-title":"2019 update of the EULAR recommendations for the management of systemic lupus erythematosus","volume":"78","author":"Fanouriakis","year":"2019","journal-title":"Ann Rheumat Dis"},{"key":"R12-20250806","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000527223","article-title":"Comparative efficacy and safety of biological agents in the treatment of lupus nephritis: a network meta-analysis","volume":"108","author":"Lee","year":"2023","journal-title":"Pharmacology"},{"key":"R13-20250806","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.3390\/cells12202440","article-title":"Voclosporin: unique chemistry, pharmacology and toxicity profile, and possible options for implementation into the management of lupus nephritis","volume":"12","author":"Kale","year":"2023","journal-title":"Cells"},{"key":"R14-20250806","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.3389\/fimmu.2019.01744","article-title":"Glucocorticoids-all-rounders tackling the versatile players of the immune system","volume":"10","author":"Strehl","year":"2019","journal-title":"Front Immunol"},{"key":"R15-20250806","doi-asserted-by":"crossref","first-page":"bcr2017222096","DOI":"10.1136\/bcr-2017-222096","article-title":"Systemic lupus erythematosus presenting to hematology with pancytopenia and features of macrophage activation syndrome","volume":"2018","author":"Mistry","year":"2018","journal-title":"BMJ Case Rep"},{"issue":"suppl5","key":"R16-20250806","doi-asserted-by":"crossref","first-page":"v29","DOI":"10.1093\/rheumatology\/keaa382","article-title":"Long-term outcomes in systemic lupus erythematosus: trends over time and major contributors","volume":"59","author":"Arnaud","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"R17-20250806","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3899\/jrheum.080957","article-title":"Clinical features and prognosis of late-onset systemic lupus erythematosus: results from the 1000 faces of lupus study","volume":"37","author":"Lalani","year":"2010","journal-title":"J Rheumatol"},{"key":"R18-20250806","first-page":"001012","article-title":"A case of pancytopenia with many possible causes: how do you tell which is the right one?","volume":"6","author":"Diaz","year":"2019","journal-title":"EJCRIM"}],"container-title":["Annals of Medicine &amp; Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000001891","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T13:24:30Z","timestamp":1754486670000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000001891"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,6]]},"references-count":18,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/ms9.0000000000001891","relation":{},"ISSN":["2049-0801"],"issn-type":[{"value":"2049-0801","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,6]]},"assertion":[{"value":"2023-10-21","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-02-19","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}